Abstract
It is known that nitric oxide (NO) exerts numerous physiological activities in mammals and it is considered a key mediator in many skin disorders. NO is synthesized in human skin cells where it regulates diverse physiological mechanisms such as dermal blood flow, wound healing, skin pigmentation, and aging. The great challenge of NO-based therapies is to preserve the biological activity of this ephemeral free radical. To this end, new biomaterials have been emerging as platforms for NO release for diverse biomedical applications. This review will discuss the new strategies for releasing/generating controlled amounts of NO for several dermatological applications through the use of nanotechnology.
Keywords: Nitric oxide, nanoparticles, skin, wound healing, antibacterial, topical applications
Current Nanoscience
Title:Nanotechnology Allied to Nitric Oxide Release Materials for Dermatological Applications
Volume: 8 Issue: 4
Author(s): Amedea B. Seabra and Nelson Duran
Affiliation:
Keywords: Nitric oxide, nanoparticles, skin, wound healing, antibacterial, topical applications
Abstract: It is known that nitric oxide (NO) exerts numerous physiological activities in mammals and it is considered a key mediator in many skin disorders. NO is synthesized in human skin cells where it regulates diverse physiological mechanisms such as dermal blood flow, wound healing, skin pigmentation, and aging. The great challenge of NO-based therapies is to preserve the biological activity of this ephemeral free radical. To this end, new biomaterials have been emerging as platforms for NO release for diverse biomedical applications. This review will discuss the new strategies for releasing/generating controlled amounts of NO for several dermatological applications through the use of nanotechnology.
Export Options
About this article
Cite this article as:
B. Seabra Amedea and Duran Nelson, Nanotechnology Allied to Nitric Oxide Release Materials for Dermatological Applications, Current Nanoscience 2012; 8 (4) . https://dx.doi.org/10.2174/157341312801784159
DOI https://dx.doi.org/10.2174/157341312801784159 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multimodality Imaging of RNA Interference
Current Medicinal Chemistry Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment
Current Gene Therapy Star Graphs of Protein Sequences and Proteome Mass Spectra in Cancer Prediction
Current Proteomics HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
Mini-Reviews in Medicinal Chemistry In Vitro and In Vivo Investigations into the Carbene Gold Chloride and Thioglucoside Anticancer Drug Candidates NHC-AuCl and NHC-AuSR
Letters in Drug Design & Discovery Mixed Micelles as Nano Polymer Therapeutics of Docetaxel: Increased In vitro Cytotoxicity and Decreased In vivo Toxicity
Current Drug Delivery Protein Microarrays for Studies of Drug Mechanisms and Biomarker Discovery in the Era of Systems Biology
Current Pharmaceutical Design The Role of Insulin-Like Growth Factor I Components in the Regulation of Vitamin D
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
Current Cancer Drug Targets Molecular Pathways Involved in Apoptotic Cell Death in the Injured Cochlea: Cues to Novel Therapeutic Strategies
Current Pharmaceutical Design Bioactivity of Chitosan and Its Derivatives
Current Organic Chemistry Liposheres as a Novel Carrier for Lipid Based Drug Delivery: Current and Future Directions
Recent Patents on Drug Delivery & Formulation Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis
Current Cancer Drug Targets Peptide Nucleic Acids with a Structurally Biased Backbone: Effects of Conformational Constraints and Stereochemistry
Current Topics in Medicinal Chemistry The use of nanocarriers in acute myeloid leukaemia therapy: challenges and current status.
Current Pharmaceutical Biotechnology Pharmacogenomics of Non-Small Cell Lung Cancer
Current Pharmacogenomics Imaging in the Age of Molecular Medicine: Monitoring of Anti-Angiogenic Treatments
Current Pharmaceutical Biotechnology Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway
Current Cancer Drug Targets Targeting the JAK/STAT Signaling Pathway for Breast Cancer
Current Medicinal Chemistry EDITORIAL [Hot Topic: Endometriosis and Women’s Health (Guest Editor: Angelos Daniilidis)]
Current Women`s Health Reviews